Nuclear Medicine: Page 323

IBA finalizes acquisition of CIS bio

By AuntMinnie.com staff writers

Belgian radiopharmaceutical firm Ion Beam Applications (IBA) of Louvain-la-Neuve has moved to finalize its purchase of CIS bio International.

May 29, 2008

Using coronary CTA first versus SPECT cuts costs

By Eric Barnes

SPECT myocardial perfusion imaging has long been the primary modality for evaluating coronary artery disease. But research based on payor data covering millions of patients found that initial evaluation with coronary CT angiography cut costs significantly over a year's time for patients without coronary artery disease and the patient cohort overall.

May 29, 2008

Draxis completes sale to Jubilant

By AuntMinnie.com staff writers

Draxis Health has finalized its acquisition by Jubilant Organosys of Noida, India.

May 28, 2008

AMIC starts fluorine-18 production

By AuntMinnie.com staff writers

Medical isotope producer Advanced Medical Isotope (AMIC) has begun production of fluorine-18 from its facility in Kennewick, WA.

May 27, 2008

Draxis shareholders OK Jubilant acquisition

By AuntMinnie.com staff writers

Draxis Health shareholders approved the Montreal-based radiopharmaceutical developer's acquisition by Jubilant Organosys of Noida, India, for $255 million (U.S.) or $6 per share.

May 22, 2008

SNM explores feasibility of U.S. medical isotope source

By Wayne Forrest

Last week's announcement by Atomic Energy of Canada (AECL) to discontinue the development of two new nuclear reactors for producing medical isotopes has the nuclear medicine community scrambling to develop alternative sources. One option is creating a source for medical isotope production within the U.S., according to the president of the SNM.

May 21, 2008